Stock 4594 BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company BrightPath Biotherapeutics Co., Ltd.

Equities

4594

JP3274140007

Biotechnology & Medical Research

Market Closed - Japan Exchange
Other stock markets
 11:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
59 JPY 0.00% Intraday chart for BrightPath Biotherapeutics Co., Ltd. +5.36% -32.18%
2023 BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited CI
2023 BrightPath Biotherapeutics Co., Ltd. announced that it expects to receive ¥5.1678 million in funding from Macquarie Group Limited CI

Business Summary

BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and abroad. The Company also generates the revenues from license fees from the pharmaceutical companies.

Number of employees: 42

Sales per Business

JPY in Million2022Weight2023Weight Delta
Other
94.7 %
15 97.4 % 5 94.7 % -66.67%
Research and Development
5.3 %
0 2.6 % 0 5.3 % -31.37%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
15 100.0 % 5 100.0 % -65.73%

Managers

Managers TitleAgeSince
Kenichi Nagai CEO
 Chief Executive Officer 53 01/09/01
Norihiro Nakamura BRD
 Director/Board Member 55 01/16/01

Members of the board

Members of the board TitleAgeSince
Hirotaka Takeuchi BRD
 Director/Board Member 77 01/15/01
Akira Yamada BRD
 Director/Board Member 67 01/03/01
Kenichi Nagai CEO
 Chief Executive Officer 53 01/09/01
Norihiro Nakamura BRD
 Director/Board Member 55 01/16/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 70,741,300 67,569,399 ( 95.52 %) 1 ( 0.000001 %) 95.52 %

Shareholders

NameEquities%Valuation
Mitsubishi UFJ Capital Co., Ltd.
0.6388 %
450,000 0.6388 % 199 215 ¥
Hiroshi Akeo
0.6388 %
450,000 0.6388 % 199 215 ¥
Akira Nishimura
0.5111 %
360,000 0.5111 % 159 372 ¥
Kazuhiko Kaneko
0.5044 %
355,300 0.5044 % 157 291 ¥
Takehiko Nakazato
0.4969 %
350,000 0.4969 % 154 945 ¥
Toshiaki Kazura
0.4645 %
327,200 0.4645 % 144 851 ¥
Kenichi Nagai
0.3407 %
240,000 0.3407 % 106 248 ¥
Akira Yamada
0.2626 %
185,000 0.2626 % 81 900 ¥
THE CHIKUHO BANK, LTD.
0.0710 %
50,000 0.0710 % 22 135 ¥
SPARX Asset Management Co., Ltd.
0.0473 %
33,300 0.0473 % 14 742 ¥

Company contact information

BrightPath Biotherapeutics Co., Ltd.

Life Innovation Center, 412 3-25-22 Tono-machi

210-0821, Kanagawa

+

http://www.brightpathbio.com
address BrightPath Biotherapeutics Co., Ltd.(4594)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BRIGHTPATH BIOTHERAPEUTICS CO., LTD. Stock BrightPath Biotherapeutics Co., Ltd.
-32.18% 26.51M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 4594 Stock
  4. Company BrightPath Biotherapeutics Co., Ltd.